P

Inventor

DAHMANN GEORG

DE58 patents
⚠️ This page may combine multiple inventors who share the name “DAHMANN GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER INGELHEIM INT

25 patents
US10154990B2Dec 18, 2018

Medicaments for the treatment or prevention of fibrotic diseases

BOEHRINGER INGELHEIM INT15 citations82
US7371743B2May 13, 2008

Carboxylic acid amides, the preparation thereof and their use as medicaments

BOEHRINGER INGELHEIM INT5 citations73
US11578080B2Feb 14, 2023

Thienopyrimidones

BOEHRINGER INGELHEIM INT2 citations70
US11136336B2Oct 5, 2021

Thienopyrimidones

BOEHRINGER INGELHEIM INT2 citations70
US9845314B2Dec 19, 2017

Pyrazolyl-substituted heteroaryls and their use as medicaments

BOEHRINGER INGELHEIM INT4 citations70
US10849907B2Dec 1, 2020

Imidazopyridine derivatives and the use thereof as medicament

BOEHRINGER INGELHEIM INT1 citations62
US7947700B2May 24, 2011

Carboxylic acid amides, the preparation thereof and their use as medicaments

BOEHRINGER INGELHEIM INT2 citations62
US7732466B2Jun 8, 2010

Substituted thiophene carboxamides, process for their preparation and their use as medicaments

BOEHRINGER INGELHEIM INT5 citations62
US11878981B2Jan 23, 2024

Substituted 1,2,4-oxadiazoles as TRPA1 inhibitors

BOEHRINGER INGELHEIM INT0 citations61
US12497401B2Dec 16, 2025

Substituted tetrazoles as TRPA1 inhibitors

BOEHRINGER INGELHEIM INT0 citations60
US12065427B2Aug 20, 2024

Heterocyclic compounds capable of activating STING

BOEHRINGER INGELHEIM INT1 citations60
US10947243B2Mar 16, 2021

Heteroaryl SYK inhibitors

BOEHRINGER INGELHEIM INT0 citations56
US9676781B2Jun 13, 2017

Substituted glycinamides, process for their manufacture and use thereof as medicaments

BOEHRINGER INGELHEIM INT0 citations52
US10155751B2Dec 18, 2018

Pyrazolyl-substituted heteroaryls and their use as medicaments

BOEHRINGER INGELHEIM INT0 citations51
US7615549B2Nov 10, 2009

Substituted pyrrolidinones, their manufacture and their use as medicaments

BOEHRINGER INGELHEIM INT2 citations51
US11304929B2Apr 19, 2022

Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors

BOEHRINGER INGELHEIM INT0 citations50
US11001570B2May 11, 2021

6-amino-quinolinone compounds and derivatives as BCL6 inhibitors

BOEHRINGER INGELHEIM INT0 citations50
US9187478B2Nov 17, 2015

Substituted naphthyridines and their use as medicaments

BOEHRINGER INGELHEIM INT0 citations50
US9199937B2Dec 1, 2015

Substituted quinolines and their use as medicaments

BOEHRINGER INGELHEIM INT0 citations49
US9914735B2Mar 13, 2018

Heteroaryl Syk inhibitors

BOEHRINGER INGELHEIM INT0 citations47
US11174245B2Nov 16, 2021

Benzimidazole compounds and derivatives as EGFR inhibitors

BOEHRINGER INGELHEIM INT0 citations46
US8003639B2Aug 23, 2011

Substituted prolinamides, the preparation thereof and the use thereof as pharmaceutical compositions

BOEHRINGER INGELHEIM INT0 citations41
US7807693B2Oct 5, 2010

Substituted prolinamides, manufacturing, and the use thereof as medicaments

BOEHRINGER INGELHEIM INT0 citations41
US7714000B2May 11, 2010

Substituted pyrrolidinones and their use as medicaments

BOEHRINGER INGELHEIM INT0 citations41
US12421218B2Sep 23, 2025

Substituted pyrazine-carboxamide derivatives

BOEHRINGER INGELHEIM INT0 citations40

DAHMANN GEORG

4 patents

BOEHRINGER INGELHEIM PHARMA

3 patents

THOMAE GMBH DR K

3 patents

PRIEPKE HENNING

3 patents

GOTTSCHLING DIRK

2 patents

GRAUERT MATTHIAS

2 patents

HOFFMANN MATTHIAS

2 patents

RUDOLF KLAUS

2 patents

HEIMANN ANNEKATRIN

1 patent

GERLACH KAI

1 patent

MANTOULIDIS ANDREAS

1 patent

WAGNER HOLGER

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.